Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Traumatic Brain Injury l: Introduction01:28

Traumatic Brain Injury l: Introduction

DefinitionTraumatic brain injury, or TBI, is a disturbance of normal brain function induced by an external mechanical force, such as a direct blow to the head or a penetrating injury. It can affect both brain structure and function, producing a wide range of clinical outcomes. TBI is a heterogeneous condition, meaning its effects may differ based on the type, location, and severity of the injury.Basis of ClassificationTBI is classified based on severity, injury mechanism, or pathophysiology. In...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Primary Blast-Induced Traumatic Brain Injury as a Risk Factor for (Cerebro)vascular Disorder: Clinical Manifestations, Blast Physics, Biomechanics, Pathobiology, and Critical Gaps.

International journal of molecular sciences·2026
Same author

Dectin-1 signaling promotes Galectin-3 shedding and expansion of immunosuppressive CD71+ erythroid cells in breast cancer.

Oncoimmunology·2026
Same author

Impact of Education, Sex, and Residence on Tinnitus Distress, Depression, and Anxiety.

Audiology research·2026
Same author

PM2.5 toxin benzo[a]pyrene induces life-limiting inflammation and oxidative stress in the airway by up-regulation of TRPC6 and inactivation of β2AR/CFTR signaling.

bioRxiv : the preprint server for biology·2026
Same author

Corrigendum to "A non-randomized phase 2 trial of pembrolizumab in untreated patients with carcinoma of unknown primary site" [Eur J Cancer (2026) 239 116709].

European journal of cancer (Oxford, England : 1990)·2026
Same author

A non-randomized phase 2 trial of pembrolizumab in untreated patients with carcinoma of unknown primary site.

European journal of cancer (Oxford, England : 1990)·2026
Same journal

Development and Standardization of a Simple Zebrafish Larval Model of Global Hypoxia-Reoxygenation: Recapitulating Key Pathological Features Associated with Cerebral Ischemia-Reperfusion Injury.

Journal of neuroscience methods·2026
Same journal

Metal Neurotoxicity assessment: a new imaging and analysis pipeline for primary neurons in co-cultures.

Journal of neuroscience methods·2026
Same journal

Corrigendum to "Human peripheral nerve xenografts and rat peripheral nerve allografts implanted to the striatum: Methodology and initial findings of cell-based therapy" [J. Neurosci. Methods 434 (2026) 110825].

Journal of neuroscience methods·2026
Same journal

Sombor-based graph-theoretic framework for the structural characterization of neuro-metabolic organic acids.

Journal of neuroscience methods·2026
Same journal

Pupil-DLC: An open-source deep learning pipeline for scalable, marker-less tracking of pupil dynamics across conscious and unconscious states.

Journal of neuroscience methods·2026
Same journal

Time as the language of Behavior: events, sequences, patterns and meanings.

Journal of neuroscience methods·2026
See all related articles

Related Experiment Video

Updated: Jun 10, 2026

Stereotactic Atlas-Guided Laser Capture Microdissection of Brain Regions Affected by Traumatic Injury
09:29

Stereotactic Atlas-Guided Laser Capture Microdissection of Brain Regions Affected by Traumatic Injury

Published on: September 11, 2017

Reverse phase protein microarray technology in traumatic brain injury.

Andrea B Gyorgy1, John Walker, Dan Wingo

  • 1Department of Anatomy, Physiology and Genetics, School of Medicine, Uniformed Services University of Health Sciences, Bethesda, MD 20814, USA. agyorgy@usuhs.mil

Journal of Neuroscience Methods
|August 3, 2010
PubMed
Summary
This summary is machine-generated.

Reverse phase protein microarray (RPPA) offers high throughput proteomics for complex diseases like cancer. This study addresses RPPA challenges, improving its use for systems biology insights.

More Related Videos

Acute Brain Trauma in Mice Followed By Longitudinal Two-photon Imaging
11:14

Acute Brain Trauma in Mice Followed By Longitudinal Two-photon Imaging

Published on: April 6, 2014

Systems Analysis of the Neuroinflammatory and Hemodynamic Response to Traumatic Brain Injury
07:21

Systems Analysis of the Neuroinflammatory and Hemodynamic Response to Traumatic Brain Injury

Published on: May 27, 2022

Related Experiment Videos

Last Updated: Jun 10, 2026

Stereotactic Atlas-Guided Laser Capture Microdissection of Brain Regions Affected by Traumatic Injury
09:29

Stereotactic Atlas-Guided Laser Capture Microdissection of Brain Regions Affected by Traumatic Injury

Published on: September 11, 2017

Acute Brain Trauma in Mice Followed By Longitudinal Two-photon Imaging
11:14

Acute Brain Trauma in Mice Followed By Longitudinal Two-photon Imaging

Published on: April 6, 2014

Systems Analysis of the Neuroinflammatory and Hemodynamic Response to Traumatic Brain Injury
07:21

Systems Analysis of the Neuroinflammatory and Hemodynamic Response to Traumatic Brain Injury

Published on: May 27, 2022

Area of Science:

  • Proteomics
  • Systems Biology
  • Biotechnology

Background:

  • Complex disorders like cancer and stroke require advanced pathobiological understanding.
  • Mass spectrometry-based proteomics faces challenges in sample complexity, sensitivity, quantification, reproducibility, and throughput.
  • Reverse phase protein microarray (RPPA) is a high throughput technology that can complement mass spectrometry.

Purpose of the Study:

  • To identify and overcome current technical challenges associated with RPPA.
  • To enhance the utility of RPPA for high throughput validation and quantification in proteomics.
  • To advance the understanding of complex disorders through systems biology approaches.

Main Methods:

  • Implementation of stringent quality control measures for RPPA.
  • Development of improved bioinformatics analysis pipelines for RPPA data.
  • Refined protocols for antibody selection, sample preparation, and data interpretation in RPPA.

Main Results:

  • Demonstration of strategies to mitigate common RPPA technical issues.
  • Validation of RPPA as a robust method for high throughput proteomics.
  • Establishment of a framework for reliable quantification and analysis of RPPA data.

Conclusions:

  • Overcoming technical challenges enhances RPPA's role in proteomics and systems biology.
  • Stringent quality control and advanced bioinformatics are crucial for RPPA success.
  • RPPA, when optimized, significantly contributes to understanding complex disease pathobiology.